SCHEMBL4089846

SCHEMBL4089846

CCc1cc(-c2ccc(-c3cc(N)[nH]n3)cc2)ccc1OOC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.38
MEN1 O00255 1/20 0.38
GAA P10253 1/20 0.38
KMT2A Q03164 1/20 0.38
ALDH1A1 P00352 2/20 0.37
LMNA P02545 1/20 0.37
ALPL P05186 5/20 0.36
CA9 Q16790 2/20 0.36
CA12 O43570 1/20 0.36
RAB9A P51151 4/20 0.36
NPC1 O15118 3/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PDE4A P27815 2/20 0.36
PDE4B Q07343 2/20 0.36
PDE4C Q08493 2/20 0.36
PDE4D Q08499 2/20 0.36
MAPK1 P28482 1/20 0.35
TP53 P04637 1/20 0.34
POLB P06746 1/20 0.34
CYP1A2 P05177 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4086117 0.79 HSD17B1 (0.50) MAPTMEN1GAAKMT2AALDH1A1
SCHEMBL4092430 0.78 NR1H4 (0.61) MAPTMEN1GAAKMT2AALDH1A1
SCHEMBL21775723 0.73 ALPL (0.58) MAPTALDH1A1ALPLCA9CA12
SCHEMBL4097796 0.71 ALPL (0.64) MAPTMEN1GAAKMT2AALDH1A1
SCHEMBL20575703 0.70 PDE4A (0.60) MAPTMEN1GAAKMT2AALDH1A1
SCHEMBL167088 0.70 MAPT (0.67) MAPTMEN1GAAKMT2AALDH1A1
SCHEMBL4858146 0.69 ALDH1A1 (0.62) MAPTGAAALDH1A1ALPLRAB9A
SCHEMBL4092658 0.69 HSD17B1 (0.45) MAPTMEN1GAAKMT2AALDH1A1
SCHEMBL4566709 0.69 NR1H4 (0.37) MEN1KMT2ALMNAMAPK1
SCHEMBL27785802 0.68 HRH3 (0.46) MAPTALPLCA9CA12RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090186900-A1 COMPOUND STERIX LIMITED (GB) 2009-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090186900-A1 COMPOUND HSD17B2, HSD17B11, CYP17A1 MAPT 929/4885MEN1 1122/4885GAA 316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.